Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.

Official Bill Page

Loading official bill page…

21 actions

Apr 28, 2025 lower

Comp. became Pub. Ch. 295
Apr 7, 2025 lower

Companion House Bill substituted
Apr 7, 2025 lower

Sponsor(s) Added.
Apr 4, 2025 lower

Placed on Senate Regular Calendar for 4/7/2025
Apr 3, 2025 lower

Senate Reset on calendar for 4/7/2025
Apr 1, 2025 lower

Placed on Senate Regular Calendar for 4/3/2025
Mar 31, 2025 lower

Senate Reset on calendar for 4/3/2025
Mar 31, 2025 lower

Sponsor(s) Added.
Mar 28, 2025 lower

Placed on Senate Regular Calendar for 3/31/2025
Mar 24, 2025 lower

Senate Reset on calendar for 3/31/2025
Mar 24, 2025 lower

Sponsor(s) Added.
Mar 21, 2025 lower

Placed on Senate Regular Calendar for 3/24/2025
Mar 17, 2025 lower

Senate Reset on calendar for 3/27/2025
Mar 14, 2025 lower

Placed on Senate Regular Calendar for 3/17/2025
Mar 11, 2025 upper

Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0
Mar 5, 2025 lower

Placed on Senate Judiciary Committee calendar for 3/11/2025
Feb 25, 2025 lower

Action deferred in Senate Judiciary Committee to 3/11/2025
Feb 19, 2025 lower

Placed on Senate Judiciary Committee calendar for 2/25/2025
Feb 12, 2025 upper

Passed on Second Consideration, refer to Senate Judiciary Committee
Feb 10, 2025 lower

Introduced, Passed on First Consideration
Jan 28, 2025 lower

Filed for introduction